Viewing Study NCT05795361


Ignite Creation Date: 2025-12-24 @ 12:32 PM
Ignite Modification Date: 2026-01-21 @ 9:30 AM
Study NCT ID: NCT05795361
Status: AVAILABLE
Last Update Posted: 2025-04-22
First Post: 2023-03-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module